Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of ACOG Protocols for Severe Hypertension in Pregnancy
NCT02933593Withdrawn
- Sponsor
- Saint Louis University
- Start
- Aug 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial in hypertension (HTN) comparing Labetalol, Hydralazine and Nifedipine (3 arms). Primary endpoint: Time to control of central arterial pressure. Planned start Aug 2016; status: withdrawn.
02
Drugs
labetalolhydralazinenifedipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02933593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02933593.